腹部放射学会胰腺导管腺癌疾病聚焦专家组白皮书第二部分:影像技术更新与高危个体胰腺癌筛查
该白皮书由腹部放射学会胰腺导管腺癌疾病聚焦专家组制定,综述胰腺导管腺癌影像技术进展及高危个体筛查现状。文章指出传统影像在检测、表征和分期中作用明确,但新辅助治疗后疗效监测仍具挑战,双能CT、扩散加权MRI和PET/MRI等新型形态与功能成像正在研究中。同时高危人群早期筛查项目逐渐发展。
要点
- 传统影像在PDAC检测、表征和分期中作用明确,但新辅助治疗后疗效监测仍具挑战。
- 双能CT、扩散加权MRI和PET/MRI等新型形态与功能成像正在被研究以提高诊断准确性和疗效评估能力。
- 高危无症状个体早期检测PDAC及其前驱病变的筛查项目逐渐发展,以期提高治愈可能性。
核心结论
- 传统影像在PDAC检测、表征和分期中作用已确立,但新辅助治疗后疗效监测因PDAC复杂的解剖和组织学特性仍具挑战。
- 新型形态和功能成像技术(如双能CT、扩散加权MRI和PET/MRI)正在被研究以提高诊断准确性和测量治疗反应的能力。
- 高危无症状个体早期检测PDAC及其前驱病变的兴趣日益增长,推动了胰腺癌筛查项目的发展。
研究设计与样本
- 本文为腹部放射学会胰腺导管腺癌疾病聚焦专家组发布的白皮书第二部分,综述影像技术更新及高危个体筛查与监测现状。
临床应用与阅片要点
- 传统影像可用于PDAC的检测、表征和分期。
- 新辅助治疗后疗效监测因PDAC复杂的解剖和组织学特性仍具挑战。
- 双能CT、扩散加权MRI和PET/MRI等新型形态和功能成像正在被研究以提高诊断准确性和测量治疗反应的能力。
- 高危无症状个体可通过胰腺癌筛查项目进行早期检测PDAC及其前驱病变,以提高治愈可能性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive gastrointestinal malignancy with a poor 5-year survival rate. Its high mortality rate is attributed to its aggressive biology and frequently late presentation. While surgical resection remains the only potentially curative treatment, only 10-20% of patients will present with surgically resectable disease. Over the past several years, development of vascular bypass graft techniques and introduction of neoadjuvant treatment regimens have increased the number of patients who can undergo resection with a curative intent. While the role of conventional imaging in the detection, characterization, and staging of patients with PDAC is well established, its role in monitoring treatment response, particularly following neoadjuvant therapy remains challenging because of the complex anatomic and histological nature of PDAC. Novel morphologic and functional imaging techniques (such as DECT, DW-MRI, and PET/MRI) are being investigated to improve the diagnostic accuracy and the ability to measure response to therapy. There is also a growing interest to detect PDAC and its precursor lesions at an early stage in asymptomatic patients to increase the likelihood of achieving cure. This has led to the development of pancreatic cancer screening programs. This article will review recent updates in imaging techniques and the current status of screening and surveillance of individuals at a high risk of developing PDAC.
引用
- Kulkarni NM, Mannelli L, Zins M, et al. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals. Abdom Radiol (NY). 2020. PMID: 31768594. doi:10.1007/s00261-019-02290-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。